Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease (vol 363, 114370, 2023)

被引：0
|
作者：
Corsi, Sara [1 ]
Scheggi, Simona [2 ]
Pardu, Alessandra [1 ]
Braccagni, Giulia [2 ]
Caruso, Donatella [3 ]
Cioffi, Lucia [2 ]
Diviccaro, Silvia [3 ,4 ]
Gentile, Mauro [1 ]
Fanni, Silvia [1 ]
Stancampiano, Roberto [1 ]
Gambarana, Carla [2 ]
Melcangi, Roberto Cosimo [3 ]
Frau, Roberto [1 ,5 ]
Carta, Manolo [1 ]
机构：
[1] Univ Cagliari, Dept Biomed Sci, Cagliari, CA, Italy
[2] Univ Siena, Dept Mol & Dev Med, Siena, SI, Italy
[3] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, MI, Italy
[4] Lund Univ, Basal Gangl Pathophysiol Unit, Dept Expt Med Sci, Lund, Sweden
[5] Univ Cagliari, Guy Everett Lab, Dept Biomed Sci, Cagliari, Italy
来源：
EXPERIMENTAL NEUROLOGY | 2024年 / 373卷
关键词：
D O I：
10.1016/j.expneurol.2023.114640
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Corsi, Sara
    Scheggi, Simona
    Pardu, Alessandra
    Braccagni, Giulia
    Caruso, Donatella
    Cioffi, Lucia
    Diviccaro, Silvia
    Gentile, Mauro
    Fanni, Silvia
    Stancampiano, Roberto
    Gambarana, Carla
    Melcangi, Roberto Cosimo
    Frau, Roberto
    Carta, Manolo
    EXPERIMENTAL NEUROLOGY, 2023, 363
  • [2] mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
    Sebastianutto, Irene
    Cenci, Maria Angela
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 81 - 89
  • [3] The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    PHARMACOLOGICAL REVIEWS, 2013, 65 (01) : 171 - 222
  • [4] L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's Disease
    Guridi, Jorge
    Obeso, Jose A.
    Rodriguez-Oroz, Maria C.
    Lozano, Andres A.
    Manrique, Miguel
    NEUROSURGERY, 2008, 62 (02) : 311 - 323
  • [5] Animal Models of L-Dopa-Induced Dyskinesia in Parkinson's Disease
    Cenci, M. Angela
    Crossman, Alan R.
    MOVEMENT DISORDERS, 2018, 33 (06) : 889 - 899
  • [6] Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia
    Fiorentini, Chiara
    Savoia, Paola
    Savoldi, Daria
    Missale, Cristina
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (08) : 1101 - 1113
  • [7] Priming for L-dopa-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?
    Nadjar, Agnes
    Gerfen, Charles R.
    Bezard, Erwan
    PROGRESS IN NEUROBIOLOGY, 2009, 87 (01) : 1 - 9
  • [8] Nalbuphine Efficacy for L-Dopa-induced Dyskinesia in Parkinson Disease
    Mouradian, M. Maral
    Papa, Stella M.
    Voronkov, Michael
    Braithwaite, Steven P.
    NEUROTHERAPEUTICS, 2016, 13 (03) : 650 - 650
  • [9] Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Urs, Nikhil M.
    Bido, Simone
    Peterson, Sean M.
    Daigle, Tanya L.
    Bass, Caroline E.
    Gainetdinov, Raul R.
    Bezard, Erwan
    Caron, Marc G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (19) : E2517 - E2526
  • [10] Repurposing drugs to treat L-DOPA-induced dyskinesia in Parkinson's disease
    Johnston, Tom H.
    Lacoste, Alix M. B.
    Visanji, Naomi P.
    Lang, Anthony E.
    Fox, Susan H.
    Brotchie, Jonathan M.
    NEUROPHARMACOLOGY, 2019, 147 : 11 - 27
12345